These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"]. Nienaber CA, Carnarius H. Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416 [Abstract] [Full Text] [Related]
4. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, Bonow RO. Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921 [Abstract] [Full Text] [Related]
5. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging. Schröter G, Schneider-Eicke J, Schwaiger M. Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413 [Abstract] [Full Text] [Related]
6. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883 [Abstract] [Full Text] [Related]
7. Thallium-201 redistribution after early reinjection in patients with severe stress perfusion defects and ventricular dysfunction. Galli M, Marcassa C. Am Heart J; 1994 Jul; 128(1):41-52. PubMed ID: 8017283 [Abstract] [Full Text] [Related]
8. PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT. Brunken RC, Kottou S, Nienaber CA, Schwaiger M, Ratib OM, Phelps ME, Schelbert HR. Radiology; 1989 Jul; 172(1):65-73. PubMed ID: 2787037 [Abstract] [Full Text] [Related]
9. Quantitative planar imaging of glucose metabolic activity in myocardial segments with exercise thallium-201 perfusion defects in patients with myocardial infarction: comparison with late (24-hour) redistribution thallium imaging for detection of reversible ischemia. Williams KA, Taillon LA, Stark VJ. Am Heart J; 1992 Aug; 124(2):294-304. PubMed ID: 1636573 [Abstract] [Full Text] [Related]
10. Potential and limitations of Tc-99m sestamibi scintigraphy for the diagnosis of myocardial viability. Cornel JH, Arnese M, Forster T, Postma-Tjoa J, Reijs AE, Fioretti PM. Herz; 1994 Feb; 19(1):19-27. PubMed ID: 8150411 [Abstract] [Full Text] [Related]
11. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease]. vom Dahl J, Altehoefer C, Büchin P, Sheehan FH, Schwarz ER, Koch KC, Schulz G, Uebis R, Schöndube F, Messmer BJ, Büll U, Hanrath P. Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949 [Abstract] [Full Text] [Related]
12. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO. Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546 [Abstract] [Full Text] [Related]
13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2010 Feb; 10(16):1-80. PubMed ID: 23074393 [Abstract] [Full Text] [Related]
14. Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction. Yamagishi H, Akioka K, Takagi M, Tanaka A, Takeuchi K, Yoshikawa J, Ochi H. Heart; 1998 Jul; 80(1):28-34. PubMed ID: 9764055 [Abstract] [Full Text] [Related]
15. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT]. Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H. Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842 [Abstract] [Full Text] [Related]
16. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study. Soufer R, Dey HM, Lawson AJ, Wackers FJ, Zaret BL. J Nucl Med; 1995 Feb; 36(2):180-7. PubMed ID: 7830110 [Abstract] [Full Text] [Related]
17. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2010 Feb; 10(15):1-45. PubMed ID: 23074392 [Abstract] [Full Text] [Related]
18. Clinical significance of reverse redistribution on 24-hour delayed imaging of exercise thallium-201 myocardial SPECT: comparison with myocardial fluorine-18-FDG-PET imaging and left ventricular wall motion. Ohte N, Hashimoto T, Banno T, Narita H, Kobayashi K, Akita S, Fujinami T. J Nucl Med; 1995 Jan; 36(1):86-92. PubMed ID: 7799089 [Abstract] [Full Text] [Related]
19. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T. J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806 [Abstract] [Full Text] [Related]
20. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. N Engl J Med; 1990 Jul 19; 323(3):141-6. PubMed ID: 2362606 [Abstract] [Full Text] [Related] Page: [Next] [New Search]